Cutaneous manifestation of HIV/AIDS: Part 2 by Dlova, N & Mosam, A




The insidious damage to the immune system by the human
immunodeficiency virus results in increasing susceptibility
to opportunistic viral infections. These can be localised,
widespread, confined to the skin, or systemic. They can
cause mild though disfiguring lesions such as molluscum
contagiosum (MCV), or lead to life-threatening infections
such as human papillomavirus (HPV-induced squamous
cell carcinoma.
Viral opportunistic infections represent activation of
subclinical infection (e.g. HPV, MCV) or reactivation of
latent infection, e.g. herpes simplex virus (HSV 1 and 2) or
varicella zoster virus (VZV). The incidence of opportunistic
viral infections has diminished remarkably with the advent
of highly active antiretroviral therapy (HAART).
HERPES SIMPLEX VIRUS 1 AND 2 INFECTIONS
Chronic herpetic infection was recognised early as a sign of
chronic immunosuppression and as a marker for the
presence of HIV infection, particularly in young adults.
There is a sharp rise in the incidence of HSV infection with
CD4 counts below 50. Herpes simplex infection is so
common in our patients that we can almost assume that
most wet-crusted lesions are herpetic until proven
otherwise.  A typical presentations are the rule.  With more
advanced HIV disease, lesions tend to be subacute or
chronic and indolent and response to oral antiviral therapy
tends to be less prompt. The presence of mucocutaneous
herpes simplex infection for more than 1 month is
classified as an AIDS- defining illness. In 65% of patients
with recurrent erythema multiforme there is a history of
herpes labialis or genitalis. This usually precedes the
erythema multiforme by several days to weeks and
occasionally may coincide with the herpes lesions.
With increasing immunocompromise, recurrent HSV
infection may become persistent and progressive. The
lesions are typically painful and occur at the typical sites –
perioral, anogenital and digital (Fig. 1). They enlarge and
deepen into painful ulcers (Fig. 2). When diagnosis is in
doubt, a tzanck smear or viral culture of blister fluid of an
early lesion (< 72 hours) is recommended; this usually takes
about 1 - 5 days. Viral culture is the easiest way to make a
diagnosis and can differentiate HSV 1 from HSV 2, but
lesions must be in an early stage. If lesions are atypical or
have been present for some time, other diagnostic
modalities such as biopsy or polymerase chain reaction
(PCR) may be considered. 
Variations in clinical manifestations can occur as a result of
the location of the lesions. Genital HSV infection can
manifest as oedema, ulcers, crusts, fissures, erythematous
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VIRAL INFECTIONS
Fig. 1. Herpes simplex infection in a patient with early 
HIV infection.
Fig. 2. Herpes simplex ulcerating penile lesions.
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patches, pustules or fleeting irritations. HSV infection in the
anal region may resemble a traumatic lesion, while inguinal
crease lesions can result in ‘kissing’ or adjacent lesions.
Virtually all patients who have had symptomatic primary
genital disease caused by HSV 2 will experience both
symptomatic recurrence and asymptomatic shedding.
However, no matter what the viral type and how infrequent
the recurrences, asymptomatic viral shedding is a feature
of HSV disease. Physicians are therefore obliged to warn
patients of these facts and to advise appropriate
prophylactic measures. The lower the CD4 cell count the
greater the likelihood of shedding.
HSV infection is treated with aciclovir 400 mg tid,
famciclovir 125 mg bid or valaciclovir 500 mg bid for 5 - 14 
days. Recurrences are common, but prophylactic therapy is
discouraged as the condition is not life-threatening and
resistant strains which are very difficult to treat may
develop after prolonged prophylaxis. If suppressive therapy
is required, aciclovir 200 - 400 mg bid for up to 1 year has
been advocated in cases with very frequent relapses. Early 
administration, preferably in the prodromal phase, is
critical and maximises the value of treatment.
Cytomegalovirus can induce lesions similar to HSV and skin
biopsy may be necessary to differentiate between the two
conditions.
Foscarnet and cidofovir are administered intravenously for
infections caused by aciclovir-resistant HSV. Imiquimod 5%
cream has been used as topical treatment for cutaneous
herpetic infections including those caused by aciclovir-
resistant HSV strains.
VARICELLA ZOSTER VIRUS (VZV)
Herpes zoster (shingles)
Varicella zoster virus causes herpes zoster or shingles.
Primary VZV infection presents as chickenpox, usually in
childhood, and can then reactivate as  herpes zoster in later
life. HIV-related zoster may be recurrent, haemorrhagic,
multidermatomal, disseminated or ulcerated (Fig. 3).
The head, neck and trunk are commonly affected. The initial
extent and severity of the herpes zoster infection, severity
of pain, and cranial (Fig. 4) and cervical dermatomal
involvement are often associated with a poorer outcome.
Disseminated herpes zoster (Fig. 5), defined as cutaneous
involvement of more than three contiguous dermatomes,
more than 20 lesions scattered outside the initial
dermatome or systemic infection (hepatitis, encephalitis,
pneumonitis), may also develop more commonly in
immunosuppressed patients.
Latent VZV infection can present with a clinical pattern of
scattered vesicles in the absence of dermatomal herpes
zoster.
Treatment with oral antivirals within 72 hours (or if  lesions
have been present for more than 72 hours, in the presence
of new active lesions) is usually effective. Early treatment
accelerates healing of skin lesions, decreases the duration
of acute pain and may decrease the frequency of post-
herpetic neuralgia (PHN).
Fig. 3. Herpes zoster.
Fig. 4. Post-herpetic scarring (PHN).
Fig. 5. Disseminated zoster.
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Treatment is with aciclovir 800 mg po 5 times a day for 7
days or valaciclovir 1 g 3 times a day for 7 days or
famciclovir 500 mg three times a day for seven days.  The
lesions are painful and attention should be given to
adequate analgesia, e.g. paracetamol-codeine. Stronger
analgesics may be required for the acute attack but should
be avoided later.
It is important to look out for PHN, which is a common
complication of HIV-related zoster and manifests as pain in
the area of the lesions once they have cleared. It should be
treated with analgesics with or without amitryptiline
nocturnally.
VARICELLA (CHICKENPOX)
In chickenpox, the rash presents as a vesicular eruption on
an erythematous base which may become pustular and
crusted (Fig. 6). The rash tends to involve the face and trunk
more than the limbs. In HIV it tends to become more dense
and more extensive, may ulcerate and may involve systemic
organs. Chickenpox may be confused with disseminated
HSV infection or disseminated zoster. Especially in children,
it may be an extensive mucocutaneous disease with
repeated new crops of vesicles, which may necrotise and
become haemorrhagic. If left untreated this has a high
mortality in immune-suppressed individuals.  Even though
the diagnosis is usually made on clinical findings alone,
when in doubt isolation of virus on viral culture from
vesicular skin lesions confirms the diagnosis. Cytological
examination of fluid or scraping from the base of a vesicle
or pustule (tzanck smear) shows both giant and
multinucleated epidermal cells, but cannot differentiate
from herpes zoster or HSV infection. The following
complications may occur and are seen more frequently in
immunocompromised individuals: hepatitis, pneumonitis,
encephalitis, and less commonly arthritis, carditis, nephritis
and orchitis.
Varicella-zoster immunoglobulin may reduce the severity
of chickenpox if given within 72 hours of exposure. Oral
aciclovir, valaciclovir or famciclovir are effective and may
reduce the severity of the infection and recurrence.
Symptomatic treatment of pruritus can be achieved with
the use of systemic antihistamines. Treatment of bacterial
secondary skin infection with the use of antibiotics may be
required. Secondary bacterial infections such as
staphylococcal pneumonia can be life threatening.
Disseminated varicella in the immunocompromised host is
treated with intravenous acyclovir.
MOLLUSCUM CONTAGIOSUM
Molluscum contagiosum is a common infection in HIV and
typically presents with umbilicated flash-coloured, dome-
shaped lesions (Fig. 7). In most cases molluscum
contagiosum is self-limiting, and in adults it is most often
sexually transmitted. It is seen more frequently in the
paediatric population. In AIDS patients, molluscum
contagiosum lesions can be widespread, attain immense
size (giant molluscum) (Fig. 8) and have unusual locations.
Fig. 6. Chickenpox.
Fig. 7. Molluscum contagiosum. 
Fig. 8. Giant molluscum contagiosum.
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The extent and size of the lesions is often related to the
degree of immune compromise. In HIV-infected individuals
it tends to be progressive and recurrent and very
recalcitrant to therapy. Local treatment includes potassium
hydroxide, silver nitrate, trichloroacetic acid or liquid
nitrogen. Patients may need repeated applications.
Cryotherapy, electrocautery and imiquimod 5% cream may
be tried though the latter is expensive. There is often
complete resolution of lesions in those patients who
recieve HAART. Diagnosis can be confirmed by biopsy, and
if there is reason to suspect another diagnosis, the
specimen can be sent for fungal culture and histology. In
more severely immune suppressed individuals, the
differential diagnosis includes cryptococcosis and
histoplasmosis. Systemic illness associated with variable
morphology of lesions should alert the clinician. 
CYTOMEGALOVIRUS
Although ulcers can occur anywhere, lesions are commonly 
seen as perianal ulceration (Fig. 9) and may be mistaken for
genital herpes ulceration. The most common sites of
infection are adrenal gland (75%), lungs (58%),
gastrointestinal tract (30%), and central nervous system
(20%). Biopsy of the skin lesion for histology and culture
will help to differentiate it from HSV.  
HUMAN PAPILLOMAVIRUS INFECTIONS
Verruca vulgaris
Human papillomaviruses commonly produce skin lesions
during the course of HIV disease. In contrast to other
opportunistic viral infections, the incidence of HPV
Fig. 9. Cytomegalovirus.
Fig. 12. Verruca planar (epidermodysplasia verruciformis-like
lesions, shins).
Fig. 11. Verruca planar (epidermodysplasia verruciformis-like
lesions, face).
Fig. 10. Verruca vulgaris.
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infections may actually increase despite patients being on
HAART. A variety of skin lesions may be seen, ranging from
verruca vulgaris (Fig. 10), which can enlarge and become
confluent, to an unusual pattern of extensive verruca plana
and pityriasis versicolor-like warts which may resemble
epidermodysplasia verruciformis (Figs 11 and 12). These
lesions tend to be unresponsive to therapy. Treatment
modalities include use of cryotherapy, electrocautery,
surgical excision and use of imiquimod.
Genital warts
HPV 6 and 11 tend to infect mucosal areas causing
condylomata acuminata, which can be  large (Figs 13 and
14). In the immune-compromised individual condylomas
are more common, more extensive and resistant to
treatment. They are often associated with vulvar
intraepithelial neoplasia and squamous carcinoma, and
cervical and anal intraepithelial neoplasia. Diagnosis is
usually made by recognition but biopsies should be
performed if lesions look atypical, or if the warts are
resistant to conventional treatment or become
hyperpigmented, indurated, fixed or ulcerated. Apply
podophyllin 25% to anogenital warts weekly (not in
pregnancy). Wash off after 4 hours to prevent irritation.
Alternatively apply 80% trichloroacetic acid in water
weekly. Cautery, liquid nitrogen or laser therapy may be
required but recurrences do occur. 
Fig. 14. Condyloma acuminatum.
Part 1 of the article 'Cutaneous manifestations of
HIV/AIDS', which appeared on pp. 12 - 17 of the
November 2004 issue of the Southern African Journal of
HIV Medicine, contained a sentence that could be
misleading. On p. 15 (left-hand column) the dosage of
amphotericin B for treating the acute stage of
histoplasmosis is given as 15 mg/kg. The dosage is in fact
0.7 mg/kg/d. 
In response to a reader query, the authors have also
clarified the dosage of fluconazole. On p. 13 (right-hand
column) it was stated that when oesophageal candidiasis
is suspected, fluconazole 100 mg/d should be given for 5
days. The treatment for oral candidiasis that is not
responsive to topical treatments is 100 mg fluconazole
once per day. If oesophageal candidiasis is suspected
(dysphagia with oral candida) the dosage is 200 mg
fluconazole daily for 2 - 3 weeks.
ERRATUM
Fig. 13. Condyloma acuminatum.
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